Treatment Related Morbidity in Patients with Classical Hodgkin Lymphoma: Results of the Ongoing, Randomized Phase III HD21 Trial By the German Hodgkin Study Group

Author:

Borchmann Peter1,Moccia Alden2,Greil Richard34,Hertzberg Mark5,Schaub Valdete6,Hüttmann Andreas7,Keil Felix8,Dierlamm Judith9,Haenel Mathias10,Novak Urban11,Meissner Julia12,Zimmermann Andreas13,Mathas Stephan14,Zijlstra Josée M.15,Fosså Alexander16,Viardot Andreas17,Hertenstein Bernd18,Martin Sonja19,Giri Pratyush20,Kamper Peter21,Molin Daniel22,Kreissl Stefanie23,Fuchs Michael2425,Schneider Gundolf26,Rosenwald Andreas27,Klapper Wolfram28,Eich Hans29,Baues Christian30,Hallek Michael31,Dietlein Markus32,Kobe Carsten33,Diehl Volker34,Engert Andreas3536

Affiliation:

1. 1German Hodgkin Study Group (GHSG) and Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), University of Cologne, Cologne, Germany

2. 2Division of Medical Oncology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland

3. 3Salzburg Cancer Research Institute (SCRI) Center for Clinical Cancer and Immunology Trials (CCCIT), Salzburg, Austria and Cancer Cluster Salzburg (CCS), Salzburg, Austria

4. 4AGMT, Salzburg, Austria

5. 5Department of Clinical Haematology, Westmead Hospital, Randwick, Australia

6. 6Medizinische Klinik II, Universitätsklinikum Tübingen, Tübingen, Germany

7. 7Department of Hematology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany

8. 83rd Medical Department for Hematology and Oncology, Hanusch Hospital, Vienna, Austria

9. 9Department of Oncology and Hematology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

10. 10Department of Hematology, Oncology and Bone Marrow Transplantation, Klinikum Chemnitz, Chemnitz, Germany

11. 11Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

12. 12Medicine V, University of Heidelberg, Heidelberg, Germany

13. 13Department of Hematology/Oncology, University Hospital of Munich, LMU Munich, Munich, Germany

14. 14Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany

15. 15Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, the Netherlands, Amsterdam, Netherlands

16. 16Department of Oncology, Oslo University Hospital, Oslo, Norway

17. 17Department of Internal Medicine III, University Hospital Ulm, Ulm, Germany

18. 18Klinikum Bremen Mitte, Bremen, Germany

19. 19Department of Hematology and Oncology, Robert-Bosch-Hospital, Stuttgart, Germany

20. 20Royal Adelaide Hospital, Adelaide, Australia

21. 21Department of Hematology, Aarhus University Hospital, Aarhus, Denmark, Aarhus, Denmark

22. 22Department of Immunology, Genetics, and Pathology, Clinical and Experimental Oncology, Uppsala University, Uppsala Akademiska Hospital, Uppsala, Sweden

23. 23German Hodgkin Study Group, University Hospital Cologne, Köln, DEU

24. 24German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany

25. 25University of Cologne, German Hodgkin Study Group (GHSG) and Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Cologne, Germany

26. 26German Hodgkin Study Group, University Hospital Cologne, Cologne, Germany

27. 27Institute of Pathology, University of Wuerzburg, Wuerzburg, Germany

28. 28Department of Pathology, Hematopathology Section and Lymph Node Registry, Universitätsklinikum Schleswig-Holstein, Kiel, Germany

29. 29Department of Radiotherapy, University Hospital of Muenster, Muenster, Germany

30. 30Department of Radiooncology and Cyberknife Center, Faculty of Medicine and University of Cologne, Cologne, Germany

31. 31Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German CLL Study Group, University of Cologne, Cologne, Germany

32. 32Faculty of Medicine and University Hospital Cologne, University Hospital of Cologne, Department of Nuclear Medicine, Cologne, Germany

33. 33Department of Nuclear Medicine. Faculty of Medicine and University of Cologne, Cologne, Germany

34. 34German Hodgkin Study Group (GHSG), University of Cologne, Cologne, Germany

35. 35Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Cologne, Germany

36. 36University of Cologne, German Hodgkin Study Group (GHSG), Cologne, Germany

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3